Compare Elder Pharma with Torrent Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ELDER PHARMA vs TORRENT PHARMA - Comparison Results

TORRENT PHARMA 
   Change

Torrent Pharmaceuticals Ltd. is the flagship company of the Torrent Group set up in 1959. Based in Ahmedabad, it was promoted by Mr U.N. Mehta initially as Trinity Laboratories Ltd. and was later renamed to its current name. The company derives its r... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ELDER PHARMA TORRENT PHARMA ELDER PHARMA/
TORRENT PHARMA
 
P/E (TTM) x -0.2 56.7 - View Chart
P/BV x 0.1 6.0 1.7% View Chart
Dividend Yield % 0.0 0.9 -  

Financials

 ELDER PHARMA   TORRENT PHARMA
EQUITY SHARE DATA
    ELDER PHARMA
Jun-14
TORRENT PHARMA
Mar-18
ELDER PHARMA/
TORRENT PHARMA
5-Yr Chart
Click to enlarge
High Rs3801,550 24.5%   
Low Rs1881,144 16.4%   
Sales per share (Unadj.) Rs491.2354.7 138.5%  
Earnings per share (Unadj.) Rs-3.240.1 -7.9%  
Cash flow per share (Unadj.) Rs14.464.2 22.4%  
Dividends per share (Unadj.) Rs014.00 0.0%  
Dividend yield (eoy) %01.0 0.0%  
Book value per share (Unadj.) Rs376.5273.1 137.8%  
Shares outstanding (eoy) m20.54169.22 12.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.63.8 15.2%   
Avg P/E ratio x-89.333.6 -265.6%  
P/CF ratio (eoy) x19.721.0 94.0%  
Price / Book Value ratio x0.84.9 15.3%  
Dividend payout %034.9 0.0%   
Avg Mkt Cap Rs m5,833227,897 2.6%   
No. of employees `000NA14.7 0.0%   
Total wages/salary Rs m2,17911,353 19.2%   
Avg. sales/employee Rs ThNM4,083.0-  
Avg. wages/employee Rs ThNM772.3-  
Avg. net profit/employee Rs ThNM461.3-  
INCOME DATA
Net Sales Rs m10,08960,021 16.8%  
Other income Rs m2572,988 8.6%   
Total revenues Rs m10,34663,009 16.4%   
Gross profit Rs m-79213,493 -5.9%  
Depreciation Rs m3614,086 8.8%   
Interest Rs m2,7563,085 89.4%   
Profit before tax Rs m-3,6539,310 -39.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m3,7130-   
Tax Rs m1252,529 4.9%   
Profit after tax Rs m-656,781 -1.0%  
Gross profit margin %-7.822.5 -34.9%  
Effective tax rate %-3.427.2 -12.6%   
Net profit margin %-0.611.3 -5.7%  
BALANCE SHEET DATA
Current assets Rs m9,24052,623 17.6%   
Current liabilities Rs m9,99852,022 19.2%   
Net working cap to sales %-7.51.0 -749.4%  
Current ratio x0.91.0 91.4%  
Inventory Days Days46120 38.7%  
Debtors Days Days6076 78.6%  
Net fixed assets Rs m10,12485,016 11.9%   
Share capital Rs m206846 24.3%   
"Free" reserves Rs m5,58245,376 12.3%   
Net worth Rs m7,73446,222 16.7%   
Long term debt Rs m4,88941,115 11.9%   
Total assets Rs m22,882142,432 16.1%  
Interest coverage x-0.34.0 -8.1%   
Debt to equity ratio x0.60.9 71.1%  
Sales to assets ratio x0.40.4 104.6%   
Return on assets %11.86.9 169.8%  
Return on equity %-0.814.7 -5.8%  
Return on capital %22.314.2 157.2%  
Exports to sales %3.00-   
Imports to sales %0.40-   
Exports (fob) Rs m307NA-   
Imports (cif) Rs m43NA-   
Fx inflow Rs m30714,580 2.1%   
Fx outflow Rs m1253,600 3.5%   
Net fx Rs m18110,980 1.7%   
CASH FLOW
From Operations Rs m11,7548,942 131.5%  
From Investments Rs m-561-47,070 1.2%  
From Financial Activity Rs m-6,76234,174 -19.8%  
Net Cashflow Rs m4,432-3,655 -121.3%  

Share Holding

Indian Promoters % 39.6 71.5 55.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 7.5 7.0 106.8%  
FIIs % 16.8 12.6 133.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 36.1 8.8 410.2%  
Shareholders   16,479 26,511 62.2%  
Pledged promoter(s) holding % 77.6 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ELDER PHARMA With:   SHASUN PHARMA  WYETH LTD  GSK PHARMA  UNICHEM LAB  DR. REDDYS LAB  

Compare ELDER PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades in Green; Bajaj Finance and ICICI Bank Top Gainers(12:30 pm)

Stock markets in India are presently trading on a positive note. The BSE Sensex is trading up by 90 points and the NSE Nifty is trading up by 35 points.

Related Views on News

TORRENT PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 32.5% (Quarterly Result Update)

Jul 25, 2019 | Updated on Jul 25, 2019

For the quarter ended June 2019, TORRENT PHARMA has posted a net profit of Rs 2 bn (up 32.5% YoY). Sales on the other hand came in at Rs 20 bn (up 8.0% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

TORRENT PHARMA Announces Quarterly Results (4QFY19); Net Profit Down 166.7% (Quarterly Result Update)

May 22, 2019 | Updated on May 22, 2019

For the quarter ended March 2019, TORRENT PHARMA has posted a net profit of Rs 2 bn (down 166.7% YoY). Sales on the other hand came in at Rs 19 bn (up 7.8% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

TORRENT PHARMA Announces Quarterly Results (3QFY19); Net Profit Up 324.1% (Quarterly Result Update)

Jan 31, 2019 | Updated on Jan 31, 2019

For the quarter ended December 2018, TORRENT PHARMA has posted a net profit of Rs 2 bn (up 324.1% YoY). Sales on the other hand came in at Rs 21 bn (up 38.9% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

TORRENT PHARMA Announces Quarterly Results (2QFY19); Net Profit Down 12.3% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, TORRENT PHARMA has posted a net profit of Rs 2 bn (down 12.3% YoY). Sales on the other hand came in at Rs 19 bn (up 32.5% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

TORRENT PHARMA Announces Quarterly Results (1QFY19); Net Profit Down 13.3% (Quarterly Result Update)

Aug 6, 2018 | Updated on Aug 6, 2018

For the quarter ended June 2018, TORRENT PHARMA has posted a net profit of Rs 2 bn (down 13.3% YoY). Sales on the other hand came in at Rs 19 bn (up 36.2% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound?(The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

Rebound Riches Could be Yours With These Stocks(Profit Hunter)

Oct 4, 2019

The secret to multibagger is not big businesses, but great managements... Here's how to find them to make the most of once in a decade rebound opportunity.

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ELDER PHARMA SHARE PRICE


Sep 12, 2016 (Close)

TRACK ELDER PHARMA

  • Track your investment in ELDER PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ELDER PHARMA - PANACEA BIOTECH COMPARISON

COMPARE ELDER PHARMA WITH

MARKET STATS